601 related articles for article (PubMed ID: 6600260)
21. Purification and target cell range of in vivo elicited blast natural killer cells.
Biron CA; Pedersen KF; Welsh RM
J Immunol; 1986 Jul; 137(2):463-71. PubMed ID: 3722814
[TBL] [Abstract][Full Text] [Related]
22. Generation and characterization of purified adherent lymphokine-activated killer cells in mice.
Gunji Y; Vujanovic NL; Hiserodt JC; Herberman RB; Gorelik E
J Immunol; 1989 Mar; 142(5):1748-54. PubMed ID: 2783950
[TBL] [Abstract][Full Text] [Related]
23. Cell surface phenotype of a cloned line of human natural killer cells.
Kornbluth J; Flomenberg N; Dupont B
J Immunol; 1982 Dec; 129(6):2831-7. PubMed ID: 6982944
[TBL] [Abstract][Full Text] [Related]
24. A clonal analysis of human peripheral blood lymphocytes displaying natural killer-like activity.
Roberts K; Moore M
Eur J Immunol; 1985 May; 15(5):448-56. PubMed ID: 3873338
[TBL] [Abstract][Full Text] [Related]
25. Morphological characterization of a cell population responsible for natural killer activity.
Luini W; Boraschi D; Alberti S; Aleotti A; Tagliabue A
Immunology; 1981 Aug; 43(4):663-8. PubMed ID: 7275171
[TBL] [Abstract][Full Text] [Related]
26. Clonal and frequency analyses of tumor-infiltrating T lymphocytes from human solid tumors.
Miescher S; Whiteside TL; Moretta L; von Fliedner V
J Immunol; 1987 Jun; 138(11):4004-11. PubMed ID: 3108380
[TBL] [Abstract][Full Text] [Related]
27. Induction of proliferation in vitro of resting human natural killer cells: IL 2 induces into cell cycle most peripheral blood NK cells, but only a minor subset of low density T cells.
London L; Perussia B; Trinchieri G
J Immunol; 1986 Dec; 137(12):3845-54. PubMed ID: 3491151
[TBL] [Abstract][Full Text] [Related]
28. Thy-1+ epidermal cells proliferate in response to concanavalin A and interleukin 2.
Nixon-Fulton JL; Bergstresser PR; Tigelaar RE
J Immunol; 1986 Apr; 136(8):2776-86. PubMed ID: 2870120
[TBL] [Abstract][Full Text] [Related]
29. Interleukin 18 induces the sequential activation of natural killer cells and cytotoxic T lymphocytes to protect syngeneic mice from transplantation with Meth A sarcoma.
Micallef MJ; Tanimoto T; Kohno K; Ikeda M; Kurimoto M
Cancer Res; 1997 Oct; 57(20):4557-63. PubMed ID: 9377569
[TBL] [Abstract][Full Text] [Related]
30. Characterization of human large granular lymphocyte subpopulations: comparison of the phenotype of NK cells and of interleukin 2-dependent progenitors of cytolytic effector cells.
Allavena P; Klein R; Ortaldo JR
Nat Immun Cell Growth Regul; 1985; 4(1):7-20. PubMed ID: 3875792
[TBL] [Abstract][Full Text] [Related]
31. A novel type of human T cell clone with highly potent natural killer-like cytotoxicity divorced from large granular lymphocyte morphology.
Schneider EM; Pawelec GP; Liangru S; Wernet P
J Immunol; 1984 Jul; 133(1):173-9. PubMed ID: 6609974
[TBL] [Abstract][Full Text] [Related]
32. Synergistic proliferation and activation of natural killer cells by interleukin 12 and interleukin 18.
Lauwerys BR; Renauld JC; Houssiau FA
Cytokine; 1999 Nov; 11(11):822-30. PubMed ID: 10547269
[TBL] [Abstract][Full Text] [Related]
33. LGL-1: a non-polymorphic antigen expressed on a major population of mouse natural killer cells.
Mason L; Giardina SL; Hecht T; Ortaldo J; Mathieson BJ
J Immunol; 1988 Jun; 140(12):4403-12. PubMed ID: 2453582
[TBL] [Abstract][Full Text] [Related]
34. Rapid generation of potent and tumor-specific cytotoxic T lymphocytes by interleukin 18 using dendritic cells and natural killer cells.
Tanaka F; Hashimoto W; Okamura H; Robbins PD; Lotze MT; Tahara H
Cancer Res; 2000 Sep; 60(17):4838-44. PubMed ID: 10987295
[TBL] [Abstract][Full Text] [Related]
35. Role of interleukin 2 (IL 2) and hemopoietin-1 (H-1) in the generation of mouse natural killer (NK) cells from primitive bone marrow precursors.
Migliorati G; Cannarile L; Herberman RB; Bartocci A; Stanley ER; Riccardi C
J Immunol; 1987 Jun; 138(11):3618-25. PubMed ID: 2884255
[TBL] [Abstract][Full Text] [Related]
36. Generation of natural killer cell lines from murine long-term bone marrow cultures.
Yung YP; Okumura K; Moore MA
J Immunol; 1985 Mar; 134(3):1462-8. PubMed ID: 3968424
[TBL] [Abstract][Full Text] [Related]
37. Role of lymphokine-activated killer cells as mediators of veto and natural suppression.
Azuma E; Kaplan J
J Immunol; 1988 Oct; 141(8):2601-6. PubMed ID: 3171179
[TBL] [Abstract][Full Text] [Related]
38. Rat natural killer cell and cytotoxic T cell lysis of H-2-negative murine embryonal carcinoma cells.
Bell SM; Stern PL
Eur J Immunol; 1985 Jan; 15(1):59-65. PubMed ID: 3155686
[TBL] [Abstract][Full Text] [Related]
39. Interleukin-2-induced decrease in the buoyant density of cytotoxic cells and its relationship with proliferation.
Sarin A; Saxena RK
Nat Immun Cell Growth Regul; 1989; 8(5):279-89. PubMed ID: 2556638
[TBL] [Abstract][Full Text] [Related]
40. Specificity and phenotype of IL-2 expanded clones of human large granular lymphocytes.
Allavena P; Ortaldo JR
Diagn Immunol; 1983; 1(3):162-7. PubMed ID: 6209054
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
